CB07-Exatecan, an ADC drug-linker conjugate, is utilized in the synthesis of ADCs and has demonstrated effectiveness in inhibiting the growth of HER2-positive cancer cells when conjugated with trastuzumab. This compound is valuable in cancer research [1].
Molekulargewicht:
1472.56
CAS Nummer:
[2879247-31-9]
Formel:
C71H94FN11O22
Target-Kategorie:
Drug-Linker Conjugates for ADC|||Topoisomerase
T87855
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten